-
Corticosteroid-free Immunosuppression in Liver Transplantation
The evidence available to date does not unequivocally establish an overall benefit of corticosteroid- free immunosuppression in HCV patients.
August 31, 2009
-
Immunologic Response and Pathogenic Mechanisms of Cytomegalovirus Infection in Transplant Recipients
What is the most recent evidence with respect to the pathogenesis of cytomegalovirus infection and its association with acute and chronic rejection?
April 23, 2009
-
Chronic Renal Failure After Transplantation of a Nonrenal Organ
Studies suggest that alpha-melanocyte stimulating hormone and anti-transforming growth factor monoclonal antibodies may abrogate the nephrotoxic effects of calcineurin inhibitors.
March 18, 2009
-
Impact of Pharmacogenetics and Pharmacodynamics on Transplantation
New approaches reflective of individual responses are required to monitor immunosuppressive therapy and to improve its safety and efficacy. This article reviews some of these approaches.
October 28, 2008
-
Cardiovascular Risk in Renal Transplantation
Renal transplant recipients (RTR) have a significant risk for cardiovascular (CV) disease, but with several unique factors affecting that risk. These factors and a RTR CV risk calculator are reviewed.
October 23, 2008
